Kamal Kishore1, Jeffrey A Brown2, Jennifer M Satar2, John M Hahn2, William I Bond2. 1. From the Illinois Retina and Eye Associates (Kishore, Satar), Peoria, Department of Surgery (Kishore, Brown), University of Illinois College of Medicine, Peoria Campus, Peoria, the Department of Ophthalmology (Hahn), CGH Medical Center, Sterling, and Bond Eyes Associates (Bond), Pekin, Illinois, and West Virginia School of Osteopathic Medicine (Satar), Lewisburg, West Virginia, USA. Electronic address: Kamal.kishore1963@gmail.com. 2. From the Illinois Retina and Eye Associates (Kishore, Satar), Peoria, Department of Surgery (Kishore, Brown), University of Illinois College of Medicine, Peoria Campus, Peoria, the Department of Ophthalmology (Hahn), CGH Medical Center, Sterling, and Bond Eyes Associates (Bond), Pekin, Illinois, and West Virginia School of Osteopathic Medicine (Satar), Lewisburg, West Virginia, USA.
Abstract
PURPOSE: To report 4 cases of acute postoperative endophthalmitis (POE) after uneventful temporal clear corneal topical dropless cataract surgery involving intravitreal triamcinolone-moxifloxacin (TriMoxi). SETTING: Private practice in Peoria, IL, USA. DESIGN: Retrospective noncomparative case series. METHODS: Charts of patients presenting with POE after an uneventful temporal clear corneal phacoemulsification with in-the-bag implantation of a posterior chamber intraocular lens over a 15-month period were reviewed. RESULTS: Patients presented with typical signs and symptoms of acute POE 3 to 14 days after cataract surgery. The POE resolved after 25-gauge pars plana vitrectomy and injection of intravitreal vancomycin, ceftazidime, and dexamethasone. Two of 4 eyes were culture-positive for coagulase-negative Staphylococcus. The corrected distance visual acuity at the last follow-up visit was 20/40 or better in 3 eyes, and 20/400 in 1 eye because of underlying atrophic age-related macular degeneration. CONCLUSION: Postoperative endophthalmitis can occur after dropless cataract surgery with intravitreal triamcinolone-moxifloxacin.
PURPOSE: To report 4 cases of acute postoperative endophthalmitis (POE) after uneventful temporal clear corneal topical dropless cataract surgery involving intravitreal triamcinolone-moxifloxacin (TriMoxi). SETTING: Private practice in Peoria, IL, USA. DESIGN: Retrospective noncomparative case series. METHODS: Charts of patients presenting with POE after an uneventful temporal clear corneal phacoemulsification with in-the-bag implantation of a posterior chamber intraocular lens over a 15-month period were reviewed. RESULTS:Patients presented with typical signs and symptoms of acute POE 3 to 14 days after cataract surgery. The POE resolved after 25-gauge pars plana vitrectomy and injection of intravitreal vancomycin, ceftazidime, and dexamethasone. Two of 4 eyes were culture-positive for coagulase-negative Staphylococcus. The corrected distance visual acuity at the last follow-up visit was 20/40 or better in 3 eyes, and 20/400 in 1 eye because of underlying atrophic age-related macular degeneration. CONCLUSION:Postoperative endophthalmitis can occur after dropless cataract surgery with intravitreal triamcinolone-moxifloxacin.